Dr Chun Loo Gan

Dr Chun Loo Gan is a highly trained medical oncologist with a passion for providing exceptional care to his patients. He currently practises at Greenslopes Private Hospital, Sunnybank Private Hospital and Royal Brisbane and Women's Hospital, where he works with a multidisciplinary team to develop personalised treatment plans that are tailored to each patient's unique needs.

Dr Gan obtained his Bachelor of Medicine, Bachelor of Surgery (MBBS) degree from the University of Melbourne in 2011, and completed his basic physician training at the Royal Melbourne Hospital. He later completed advanced medical oncology training at Monash Medical Centre and Olivia Newton-John Cancer Centre in Melbourne, Victoria, before becoming a Fellow of the Royal Australasian College of Physicians in 2018.

Dr Gan is a strong advocate for research and clinical trials and has completed a two-year genitourinary oncology fellowship at the Tom Baker Cancer Centre in Calgary, Canada, where he worked under the supervision of Prof. Daniel Heng, the founder of the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC). As the IMDC fellow, Dr Gan led multiple international collaborative research studies in advanced renal cell carcinoma and immunotherapy, which he has presented at international and national meetings. Dr Gan has received numerous awards for his work, including two prestigious Merit Awards from the American Society of Clinical Oncology and the Novartis Oncology Young Canadian Investigator Award. In addition, Dr Gan has completed a Masters in Cancer Sciences at the University of Melbourne with a particular focus on cancer immunotherapy.

Dr Gan is fluent in English and Mandarin and is committed to providing compassionate care to all of his patients. His clinical experience covers a broad range of solid tumour malignancies, with a special interest in genitourinary cancer, gastrointestinal cancer, breast cancer, lung cancer, and melanoma. Dr Gan is passionate about helping his patients achieve the best possible outcomes and looks forward to supporting them throughout their cancer journey.